Canadian drug company JAMP Pharma has announced the launch of generic guanfacine for the treatment of attention deficit hyperactivity disorder (ADHD). The product is bioequivalent to Takeda Canada’s Intuniv XR (guanfacine). JAMP’s product offers the same quality and it will be more affordable.